First Dallas Securities’s Supernus Pharmaceuticals SUPN Stock Holding History

First Dallas Securities’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,250	Closed	-$229K	–	116
2016 Q2	$229K	Sell	11,250 -7,650	-40%	-$136K	0.18%	94
2016 Q1	$288K	Sell	18,900 -1,300	-6%	-$17K	0.23%	77
2015 Q4	$271K	Sell	20,200 -1,150	-5%	-$17.8K	0.22%	78
2015 Q3	$300K	Buy	21,350 +1,900	+10%	+$35.3K	0.25%	70
2015 Q2	$330K	Buy	+19,450	New	+$277K	0.24%	71

Other funds holding SUPN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Dallas Securities's SUPN Position: Q3 2016 in Review

First Dallas Securities sold out of Supernus Pharmaceuticals (SUPN) in Q3 2016, closing a stake of 11,250 shares — an estimated $229K sold.

First Dallas Securities first reported a position in SUPN in Q2 2015 and held it in 5 quarters. The position peaked at $330K in Q2 2015. 221 funds tracked by Wall St. Rank hold SUPN as of Q3 2016.

First Dallas Securities reported no remaining Supernus Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
First Dallas Securities sold 11,250 Supernus Pharmaceuticals shares in Q3 2016, an estimated $229K.
First Dallas Securities first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 5 quarters.
First Dallas Securities's Supernus Pharmaceuticals position peaked at $330K in Q2 2015.
221 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2016.

Based on First Dallas Securities's 13F filing for Q3 2016, filed 15 Nov 2016.